
IMHOTEP, PJP, and more
May 14, 2026 - 00:09:59
Radio and PodcastLive Radio & Podcasts
The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients in now published in NEJM. We discuss the results and ponder potential futu...
Perioperative Enortumab vedotin + Pembrolizumab is an episode from OncoPharm by OncoPharmPod. The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published Feb 19, 2026, 00:16:30 long, audio available.
The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients in now published in NEJM. We discuss the results and ponder potential future changes to treating bladder cancer in the future. Urinary diversion surgeries:
You can listen to Perioperative Enortumab vedotin + Pembrolizumab online on Radio and Podcast. Open the player on this page to stream the available audio.
Perioperative Enortumab vedotin + Pembrolizumab is an episode from OncoPharm by OncoPharmPod.
This episode is 00:16:30 long.
This episode was published on Feb 19, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.